Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients. Int. J. Res. Clin. Hosp. Pharm. 2019;2(1):1-4. Accessed July 26, 2026. https://rubatosisjournals.com/index.php/ijrhcp/article/view/333